Geode Capital Management, LLC Prelude Therapeutics Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 391,716 shares of PRLD stock, worth $442,639. This represents 0.0% of its overall portfolio holdings.

Number of Shares

391,716

Previous 361,951 8.22%

Holding current value

$442,639

Previous $1.38 Million 41.26%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.07 - $6.37 $61,613 - $189,603	29,765 Added 8.22%	391,716 $810,000
Q2 2024 Aug 09, 2024	BUY	$3.32 - $5.63 $1,059 - $1,795	319 Added 0.09%	361,951 $1.38 Million
Q1 2024 May 13, 2024	BUY	$2.68 - $4.84 $32,870 - $59,362	12,265 Added 3.51%	361,632 $1.71 Million
Q4 2023 Feb 13, 2024	BUY	$1.69 - $4.37 $30,871 - $79,826	18,267 Added 5.52%	349,367 $1.49 Million
Q3 2023 Nov 13, 2023	BUY	$2.74 - $4.79 $243,328 - $425,380	88,806 Added 36.65%	331,100 $1.02 Million
Q2 2023 Aug 11, 2023	BUY	$4.45 - $8.12 $428,935 - $782,686	96,390 Added 66.06%	242,294 $1.09 Million
Q1 2023 May 15, 2023	BUY	$4.58 - $7.34 $5,619 - $9,006	1,227 Added 0.85%	145,904 $831,000
Q4 2022 Feb 13, 2023	SELL	$4.61 - $8.5 $38,788 - $71,519	-8,414 Reduced 5.5%	144,677 $873,000
Q3 2022 Nov 14, 2022	BUY	$5.0 - $8.82 $87,250 - $153,909	17,450 Added 12.86%	153,091 $1.01 Million
Q2 2022 Aug 12, 2022	SELL	$4.0 - $7.55 $287,740 - $543,109	-71,935 Reduced 34.65%	135,641 $708,000
Q1 2022 May 13, 2022	SELL	$6.9 - $13.22 $34,914 - $66,893	-5,060 Reduced 2.38%	207,576 $1.43 Million
Q4 2021 Feb 11, 2022	SELL	$11.89 - $31.74 $434,413 - $1.16 Million	-36,536 Reduced 14.66%	212,636 $2.65 Million
Q3 2021 Nov 12, 2021	BUY	$25.78 - $38.65 $668,217 - $1 Million	25,920 Added 11.61%	249,172 $7.79 Million
Q2 2021 Aug 13, 2021	BUY	$28.63 - $44.3 $688,866 - $1.07 Million	24,061 Added 12.08%	223,252 $6.39 Million
Q1 2021 May 12, 2021	BUY	$39.27 - $91.68 $296,999 - $693,375	7,563 Added 3.95%	199,191 $8.63 Million
Q4 2020 Feb 12, 2021	BUY	$28.81 - $88.94 $5.52 Million - $17 Million	191,628 New	191,628 $13.7 Million

Others Institutions Holding PRLD

# of Institutions

Shares Held

35.7M

Call Options Held

500

Put Options Held

300

View Full List

About Prelude Therapeutics Inc

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $41.1M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

More about PRLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Prelude Therapeutics Inc Transaction History